This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Zalewski, A. Articles by Maroko, P. R. Search for Related Content PubMed PubMed Citation Articles by Zalewski, A. Articles by Maroko, P. R.

Circulation, Vol 73, 734-739, Copyright © 1986 by American Heart Association

ARTICLES

Myocardial protection during transient coronary artery occlusion in man: beneficial effects of regional beta-adrenergic blockade

A Zalewski, S Goldberg, JP Dervan, S Slysh and PR Maroko

The goal of this study was to verify whether myocardial protection could be achieved via the intracoronary administration of propranolol in patients undergoing percutaneous transluminal coronary angioplasty (PTCA). Accordingly, 21 patients undergoing PTCA were randomly assigned to receive either intracoronary placebo (group A, n = 10) or intracoronary propranolol (group B, n = 11). Three balloon inflations (i.e., coronary artery occlusions) were performed in each patient. Inflations I and II (maximum duration 60 sec) served as control occlusions. Inflation III (maximum duration 120 sec) was performed either after intracoronary administration of saline (2 ml) or propranolol (1.1 +/- 0.2 mg). The following electrocardiographic index of myocardial ischemic injury were measured: (1) time to development of ST segment elevation equal to 0.1 mV and (2) magnitude of ST segment elevation after 60 sec of coronary artery occlusion. Both indexes did not differ significantly between the groups during inflations I and II. In group A the time to development of ST segment elevation of 0.1 mV remained unchanged between the second and third occlusions (25 +/- 5 and 26 +/- 4 sec during inflations II and III, respectively). In group B subselective injection of propranolol into the affected coronary artery significantly prolonged the time to ST segment elevation of 0.1 mV from 19 +/- 4 sec (inflation II) to 53 +/- 9 sec (inflation III; p less than .001). Administration of placebo did not change the magnitude of ST segment elevation 60 sec after coronary artery occlusion between the second and third occlusion in group A (0.16 +/- 0.02 and 0.18 +/- 0.03 mV, respectively).(ABSTRACT TRUNCATED AT 250 WORDS)

This article has been cited by other articles:

				F. W. Wang, A. Osman, J. Otero, G. A. Stouffer, S. Waxman, A. Afzal, A. Anzuini, and B. F. Uretsky Distal Myocardial Protection During Percutaneous Coronary Intervention With an Intracoronary {beta}-Blocker Circulation, June 17, 2003; 107(23): 2914 - 2919. [Abstract] [Full Text] [PDF]

				N. Danchin Recent advances in cardioprotection during myocardial revascularization procedures: benefit of a metabolic intervention Eur. Heart J. Suppl., November 1, 2001; 3(suppl_O): O21 - O25. [Abstract] [PDF]

				Y. Birnbaum, K. Przyklenk, and R. A. Kloner Time Frame of Ischemic Preconditioning: Is It Clinically Relevant? Journal of Cardiovascular Pharmacology and Therapeutics, October 1, 1996; 1(4): 339 - 346. [PDF]

				R. A. Lange, R. G. Cigarroa, E. D. Flores, W. McBride, A. S. Kim, P. J. Wells, J. B. Bedotto, R. S. Danziger, and L. D. Hillis Potentiation of Cocaine-Induced Coronary Vasoconstriction by Beta-Adrenergic Blockade Ann Intern Med, June 15, 1990; 112(12): 897 - 903. [Abstract] [PDF]